Reuters logo
a month ago
BRIEF-PDS Biotechnology enters a clinical trial collaboration agreement with a subsidiary of Merck
July 10, 2017 / 11:27 AM / a month ago

BRIEF-PDS Biotechnology enters a clinical trial collaboration agreement with a subsidiary of Merck

July 10 (Reuters) - Merck & Co Inc

* PDS Biotechnology says has entered a clinical trial collaboration agreement with a subsidiary of Merck

* Agreement to evaluate combination of PDS's lead PDS0101, with Merck's anti-PD-1 therapy, Keytruda in a phase II clinical trial

* Says details of collaboration were not disclosed Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below